Ticker brief
NNVC NANOVIRICIDES INC
Consumer, Non-cyclical · Pharmaceuticals
last close
$1.33
1 day
-1.5%
14 days
-5.0%
mkt cap
$30.6M
signals 14d
15
authors 14d
6
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-06-29 · now +0.37 (−1 bearish … +1 bullish)
Who spoke6
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @beach_trades | C | -2.81 | 9 | +0.38 |
| @OzmosiHealth | C | · | 2 | +0.33 |
| @TT_stocks_ | C | +2.39 | 1 | +0.75 |
| @OracleNYSE | C | +0.49 | 1 | +0.20 |
| @AccesswireNews | C | · | 1 | +0.50 |
| @USAnt_IDEA | C | -0.65 | 1 | +0.10 |
Recent signals15of 15 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-06-29 | @USAnt_IDEA | +0.10 | Korean biotech pipeline roundup cites FDA approvals, trial starts, and results. | -2.9% | tweet ↗ |
| 2026-06-29 | @OzmosiHealth | +0.50 | FDA granted Rare Pediatric Disease Drug designation for NV-387 as measles treatment. | -2.9% | tweet ↗ |
| 2026-06-29 | @AccesswireNews | +0.50 | US FDA grants Rare Pediatric Disease Drug designation for NV-387 as measles treatment. | -2.9% | tweet ↗ |
| 2026-06-25 | @beach_trades | +0.45 | Says NNVC lead drug candidate NV-387 could be effective against Ebola strain. | +2.3% | tweet ↗ |
| 2026-06-25 | @beach_trades | +0.30 | Links NNVC to Ebola response need as Africa CDC triples amount needed. | +2.3% | tweet ↗ |
| 2026-06-25 | @beach_trades | +0.35 | Says NNVC has potential treatment as rare Ebola strain may spread. | +2.3% | tweet ↗ |
| 2026-06-25 | @OracleNYSE | +0.20 | NYP headline says world's most contagious disease found at busy California airport in NNVC context. | +2.3% | tweet ↗ |
| 2026-06-24 | @beach_trades | +0.15 | Names NanoViricides in reply without much standalone analysis. | -2.2% | tweet ↗ |
| 2026-06-24 | @beach_trades | +0.45 | Says NNVC lead drug candidate NV-387 could be effective against Ebola strain. | -2.2% | tweet ↗ |
| 2026-06-24 | @beach_trades | +0.40 | Says NNVC and APT are early, implying bullish setup. | -2.2% | tweet ↗ |
| 2026-06-24 | @beach_trades | +0.45 | NanoViricides says its antiviral could help tackle Ebola strain behind Congo outbreak. | -2.2% | tweet ↗ |
| 2026-06-24 | @beach_trades | +0.45 | Reports NNVC candidate NV-387 may be effective against Bundibugyo Ebola strain. | -2.2% | tweet ↗ |
| 2026-06-24 | @beach_trades | +0.45 | Calls NNVC an Ebola play. | -2.2% | tweet ↗ |
| 2026-06-22 | @OzmosiHealth | +0.15 | NanoViricides shipped NV-387 oral gummies for Phase II trial. | +0.8% | tweet ↗ |
| 2026-06-22 | @TT_stocks_ | +0.75 | Bullish speculative biotech thesis on NNVC platform, milestones and 7 dollar analyst PT. | +0.8% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.